Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...
1d
Investor's Business Daily on MSNBristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 OutlookBristol Myers walloped sales views Thursday, but Bristol Myers Squibb stock took a hit on a light outlook hamstrung by ...
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to explain why he's selling Bristol Myers so ...
We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks. In this ...
Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
PHILADELPHIA – Josh Myers couldn’t have picked a worse way to venture into his uncertain future, even if the Green Bay Packers center felt he “got lucky” Sunday. “I thought I broke my leg,” Myers said ...
We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...
Jake Holter spoke with a local business owner to get his reaction. More starting at 4:30 on 12 News. Marilyn Manson won’t face sexual assault, domestic violence charges in LA Don’t overdo it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results